11. Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials. (14th August 2019) Authors: Jemec, G.B.E.; Okun, M.M.; Forman, S.B.; Gulliver, W.P.F.; Prens, E.P.; Mrowietz, U.; Armstrong, A.W.; Geng, Z.; Gu, Y.; Williams, D.A.; Teixeira, H.D.; Kimball, A.B. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials. (1st November 2019) Authors: Jemec, G.B.E.; Okun, M.M.; Forman, S.B.; Gulliver, W.P.F.; Prens, E.P.; Mrowietz, U.; Armstrong, A.W.; Geng, Z.; Gu, Y.; Williams, D.A.; Teixeira, H.D.; Kimball, A.B. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. (30th January 2020) Authors: Zouboulis, C.C.; Nogueira da Costa, A.; Makrantonaki, E.; Hou, X.X.; Almansouri, D.; Dudley, J.T.; Edwards, H.; Readhead, B.; Balthasar, O.; Jemec, G.B.E.; Bonitsis, N.G.; Nikolakis, G.; Trebing, D.; Zouboulis, K.C.; Hossini, A.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 4(2020) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Assessing the influence of actinic keratosis on patients' quality of life: the AKQoL questionnaire. (30th January 2013) Authors: Esmann, S.; Vinding, G.R.; Christensen, K.B.; Jemec, G.B.E. Journal: British journal of dermatology Issue: Volume 168:Number 2(2013:Feb.) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Assessing the quality of life over longer periods. (1st September 2014) Authors: Esmann, S.; Jemec, G.B.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 1(2016:Jan.) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. (11th November 2014) Authors: Kimball, A.B.; Jemec, G.B.E.; Yang, M.; Kageleiry, A.; Signorovitch, J.E.; Okun, M.M.; Gu, Y.; Wang, K.; Mulani, P.; Sundaram, M. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. (1st December 2014) Authors: Kimball, A.B.; Jemec, G.B.E.; Yang, M.; Kageleiry, A.; Signorovitch, J.E.; Okun, M.M.; Gu, Y.; Wang, K.; Mulani, P.; Sundaram, M. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from Hidradenitis Suppurativa lesions. (7th August 2018) Authors: Ardon, C.B.; Prens, E.P.; Fuursted, K.; Ejaz, R.N.; Shailes, J.; Jenssen, H.; Jemec, G.B.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 1(2019) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Biomarkers in hidradenitis suppurativa. (5th June 2013) Authors: Jemec, G.B.E. Journal: British journal of dermatology Issue: Volume 168:Number 6(2013:Jun.) Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta‐analysis of observational studies. (1st November 2015) Authors: Tzellos, T.; Zouboulis, C.C.; Gulliver, W.; Cohen, A.D.; Wolkenstein, P.; Jemec, G.B.E. Journal: British journal of dermatology Issue: Volume 173:Number 5(2015:Nov.) Page Start: 1142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗